Oropharyngeal colostrum administration in extremely premature infants: An RCT

Pediatrics

Volumn 135, Issue 2, 2015, Pages e357-e366

  Lee, Juyoung ^a   Kim, Han Suk ^a   Jung, Young Hwa ^a   Choi, Ka Young ^b   Shin, Seung Han ^a   Kim, Ee Kyung ^a   Choi, Jung Hwan ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Hallym University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 1BETA; LACTOFERRIN; SECRETORY IMMUNOGLOBULIN; STERILE WATER; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 8;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; MALE; ORAL IMMUNOTHERAPY; OROPHARYNGEAL COLOSTRUM ADMINISTRATION; OROPHARYNX; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SEPSIS; URINALYSIS; URINE LEVEL; BLOOD; CHEMISTRY; COLOSTRUM; ENTERIC FEEDING; EXTREMELY LOW BIRTH WEIGHT; IMMUNOLOGY; NEWBORN; PROCEDURES; SALIVA; SOUTH KOREA; UNIVERSITY HOSPITAL;

COLOSTRUM; CREATININE; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERLEUKIN-1BETA; INTERLEUKIN-8; LACTOFERRIN; REPUBLIC OF KOREA; SALIVA; SEPSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84922610962     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2004     Document Type: Article

References (39)

1. Kelleher SL, Lönnerdal B. Immunological activities associated with milk. Adv Nutr Res. 2001;10:39-65
2. Garofalo R. Cytokines in human milk. J Pediatr. 2010;156(suppl 2):S36-S40
3. Hurley WL, Theil PK. Perspectives on immunoglobulins in colostrum and milk. Nutrients. 2011;3(4):442-474
4. Lönnerdal B. Bioactive proteins in human milk: mechanisms of action. J Pediatr. 2010;156(suppl 2):S26-S30
5. Underwood MA. Human milk for the premature infant. Pediatr Clin North Am. 2013;60(1):189-207
6. Dvorak B, Fituch CC, Williams CS, Hurst NM, Schanler RJ. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res. 2003;54(1):15-19
7. Gross SJ, Buckley RH, Wakil SS, McAllister DC, David RJ, Faix RG. Elevated IgA concentration in milk produced by mothers delivered of preterm infants. J Pediatr. 1981;99(3):389-393
8. Koenig A, de Albuquerque Diniz EM, Barbosa SF, Vaz FA. Immunologic factors in human milk: the effects of gestational age and pasteurization. J Hum Lact. 2005;21(4):439-443
9. Montagne P, Cuillière ML, Molé C, Béné MC, Faure G. Immunological and nutritional composition of human milk in relation to prematurity and mother's parity during the first 2 weeks of lactation. J Pediatr Gastroenterol Nutr. 1999;29(1):75-80
10. Ronayne de Ferrer PA, Baroni A, Sambucetti ME, López NE, Ceriani Cernadas JM. Lactoferrin levels in term and preterm milk. J Am Coll Nutr. 2000;19(3):370-373
11. Gephart SM, Weller M. Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care. 2014;14(1):44-51
12. Rodriguez NA, Meier PP, Groer MW, Zeller JM. Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives. J Perinatol. 2009;29(1):1-7
13. Thibeau S, Boudreaux C. Exploring the use of mothers' own milk as oral care for mechanically ventilated very low-birth-weight preterm infants. Adv Neonatal Care. 2013;13(3):190-197
14. Rodriguez NA, Meier PP, Groer MW, Zeller JM, Engstrom JL, Fogg L. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants. Adv Neonatal Care. 2010;10(4):206-212
15. Rodriguez NA, Groer MW, Zeller JM. A randomized controlled trial of the oropharyngeal administration of mother 's colostrum to extremely low birth weight infants in the first days of life. Neonatal Intensive Care. 2011;24(4):31-35
16. Seigel JK, Smith PB, Ashley PL, et al. Early administration of oropharyngeal colostrum to extremely low birth weight infants. Breastfeed Med. 2013;8(6):491-495
17. Levy MM, Fink MP, Marshall JC, et al; International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530-538
18. Ishiguro Y, Kato K, Ito T, Nagaya M. Developmental profiles of urinary SIgA in newborns and the effect of blood transfusion. Immunology. 1982;46(2):329-332
19. Maia C, Brandão R, Roncalli A, Maranhão H. Length of stay in a neonatal intensive care unit and its association with low rates of exclusive breastfeeding in very low birth weight infants. J Matern Fetal Neonatal Med. 2011;24(6):774-777
20. Goldblum RM, Schanler RJ, Garza C, Goldman AS. Human milk feeding enhances the urinary excretion of immunologic factors in low birth weight infants. Pediatr Res. 1989;25(2):184-188
21. Hutchens TW, Henry JF, Yip TT. Purification and characterization of intact lactoferrin found in the urine of human milk-fed preterm infants. Clin Chem. 1989;35(9):1928-1933
22. Hutchens TW, Henry JF, Yip TT, et al. Origin of intact lactoferrin and its DNAbinding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment. Pediatr Res. 1991;29(3):243-250
23. Brandtzaeg P. Role of local immunity and breast-feeding in mucosal homeostasis and defense against infections. In: Calder PC, Field CJ, Gill HS, eds. Nutrition and Immune Function (Frontiers in Nutritional Science No. 1). Oxon, UK: CABI Publishing; 2002:273-320
24. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr. 2010;156(suppl 2):S8-S15
25. English BK, Burchett SK, English JD, Ammann AJ, Wara DW, Wilson CB. Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res. 1988;24(6):717-722
26. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest. 1991;87(1):194-202
27. Yachie A, Takano N, Ohta K, et al. Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens. Infect Immun. 1992;60(3):749-753
28. Chang M, Suen Y, Lee SM, et al. Transforming growth factor-beta 1, macrophage inflammatory protein-1 alpha, and interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood. 1994;84(1):118-124
29. Chheda S, Palkowetz KH, Garofalo R, Rassin DK, Goldman AS. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors. Pediatr Res. 1996;40(3):475-483
30. Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE. 2011;6(3):e17776
31. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A. 2000;97(11):6043-6048
32. 2 specifically attenuates IL-1β-induced inflammatory responses in the immature human intestine via an SMAD6- and ERK-dependent mechanism. Neonatology. 2011;99(3):192-201
33. Rezaie A, Khalaj S, Shabihkhani M, et al. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci. 2007;1095(1):305-314
34. Scarpa M, Bortolami M, Morgan SL, et al. TGF-beta1 and IGF-1 production and recurrence of Crohn's disease after ileo-colonic resection. J Surg Res. 2009;152(1):26-34
35. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology. 1996;110(4):975-984
36. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr. 2010;156(suppl 2):S3-S7
37. Claud EC, Savidge T, Walker WA. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res. 2003;53(3):419-425
38. Håversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol. 2002;220(2):83-95
39. Håversen LA, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I. Anti-inflammatory activities of human lactoferrin in acute dextran sulphate-induced colitis in mice. Scand J Immunol. 2003;57(1):2-10